2m 2m 2m 2m 2m 2m 2m
Basilea Pharmaceu N (BPMUF)
OTC
$65.10-$3.90 (-5.65%)
Price as of May 18, 2026- N/AMarket Cap
- 37.05%1-Year Change
- BiotechnologyIndustry
Basilea Pharmaceu N (BPMUF)
$65.10-$3.90 (-5.65%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$65.10
$65.10
$65.10
1-Year Range
$57.70
$74.00
$65.10
Latest Close$65.10
Change
-$3.90 (-5.99%)
Volume11
Information as of 05/18/2026
Company Profile
BASILEA PHARM AG AKT SHS
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
BASILEA PHARM AG AKT SHS
Key Executives
- David Veitch
- Mark Jones
- Damian Heller
- Gerrit Hauck
- Laurenz Kellenberger
Current Ownership Distribution
- Other12.4M (99.98%)
- Mutual Funds2,272 (0.02%)
- Institutions0 (0.00%)
- Insiders0 (0.00%)